Arcturus Therapeutics Holdings (ARCT) Accounts Payables (2018 - 2025)
Historic Accounts Payables for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to $5.5 million.
- Arcturus Therapeutics Holdings' Accounts Payables fell 4580.0% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 4580.0%. This contributed to the annual value of $7.2 million for FY2024, which is 3627.58% up from last year.
- Per Arcturus Therapeutics Holdings' latest filing, its Accounts Payables stood at $5.5 million for Q3 2025, which was down 4580.0% from $10.6 million recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Accounts Payables registered a high of $19.3 million during Q1 2023, and its lowest value of $5.3 million during Q4 2023.
- For the 5-year period, Arcturus Therapeutics Holdings' Accounts Payables averaged around $10.2 million, with its median value being $10.0 million (2022).
- In the last 5 years, Arcturus Therapeutics Holdings' Accounts Payables skyrocketed by 13635.89% in 2023 and then crashed by 5272.95% in 2024.
- Arcturus Therapeutics Holdings' Accounts Payables (Quarter) stood at $10.1 million in 2021, then dropped by 25.94% to $7.4 million in 2022, then decreased by 29.13% to $5.3 million in 2023, then skyrocketed by 36.28% to $7.2 million in 2024, then fell by 23.67% to $5.5 million in 2025.
- Its Accounts Payables was $5.5 million in Q3 2025, compared to $10.6 million in Q2 2025 and $6.2 million in Q1 2025.